Kelsell D P, Black D M, Bishop D T, Spurr N K
Imperial Cancer Reseach Fund, Clare Hall Laboratories, South Mimms, Hertfordshire, UK.
Hum Mol Genet. 1993 Nov;2(11):1823-8. doi: 10.1093/hmg/2.11.1823.
We have analyzed a single multi-affected breast/ovarian cancer pedigree (BOV3) and have shown consistent inheritance of markers on chromosome 17q with the disease confirming that this family is due to the BRCA1 gene. Analysis of 17q haplotypes shows a recombination event in a bilateral breast cancer case which suggests that the BRCA1 gene lies distal to D17S857; D17S857 is thus the new proximal boundary for the region containing BRCA1. Combining this information with previously published mapping information suggests that BRCA1 is contained in a region estimated at 1-1.5 Mb in length. All seven breast tumour/blood pairs examined from this family show loss of heterozygosity in the tumours. The allel retained in each tumour was from the disease-bearing chromosome implicating BRCA1 as a tumour suppressor gene. We have sequenced the 17 beta-oestradiol dehydrogenase genes (EDH17B1 and EDH17B2) which have been suggested as candidate genes for BRCA1 in four members of this family. No germline mutations were detected.
我们分析了一个多例乳腺癌/卵巢癌家系(BOV3),结果显示17号染色体长臂上的标记与该疾病存在一致的遗传关系,证实这个家系的病因是BRCA1基因。对17号染色体长臂单倍型的分析显示,在一例双侧乳腺癌病例中存在重组事件,这表明BRCA1基因位于D17S857的远端;因此,D17S857是包含BRCA1区域的新近端边界。将这一信息与先前发表的定位信息相结合,提示BRCA1位于一个长度估计为1 - 1.5兆碱基的区域内。从这个家系中检测的所有7对乳腺肿瘤/血液样本均显示肿瘤中杂合性缺失。每个肿瘤中保留的等位基因来自携带疾病的染色体,这意味着BRCA1是一个肿瘤抑制基因。我们对该家系4名成员中曾被认为是BRCA1候选基因的17β-雌二醇脱氢酶基因(EDH17B1和EDH17B2)进行了测序,未检测到种系突变。